Dexalax 60 mg (Capsule (Enteric Coated))
Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00)
Strip Price: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Dexlansoprazole |
Company | Delta pharma ltd |
Also available as |
Title and Categories
- Dexalax
- Proton Pump Inhibitor
- Gastrointestinal Medication
Healing of Erosive Esophagitis
Indicated for the healing of all grades of erosive esophagitis (EE) for up to 8 weeks
Maintenance of Healed Erosive Esophagitis
Indicated to maintain healing of EE and relief of heartburn for up to 6 months
Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Indicated for the treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD) for 4 weeks
Pharmacology
Proton Pump Inhibitor (PPI) suppressing gastric acid secretion by specific inhibition of the (H+/K+)-ATPase in the gastric parietal cell
Dosage
- 30 mg Once daily for maintenance of healed erosive esophagitis and relief of heartburn
- 60 mg Once daily for healing of erosive esophagitis
- One 30 mg tablet once daily for 6 months for maintenance of healed erosive esophagitis and relief of heartburn in adults
- One 30 mg tablet once daily for 4 weeks for symptomatic non-erosive GERD
Administration
- Can be taken without regard to food
- Swallowed whole or granules can be sprinkled on one tablespoon and swallowed immediately
- Granules should not be chewed
- Missed capsules should be taken as soon as possible or only the prescribed dose at the appointed time if too close to the next dose
Interaction
- With medicine: Atazanavir, Warfarin, Tacrolimus, Clopidogrel & Methotrexate
- No data available for interactions with food & others
Contraindications
Contraindicated in patients with known hypersensitivity to any component of the formulation
Side Effects
- Common side effects include diarrhea, abdominal pain, nausea, vomiting & flatulence
Pregnancy & Lactation
- Pregnancy Category B
- No adequate and well-controlled studies with Dexlansoprazole in pregnant or lactating women
Precautions & Warnings
- Precautions for Gastric Malignancy, Clostridium difficile Associated Diarrhea, Bone fracture, Hypomagnesemia, and concomitant use with Methotrexate
Use in Special Populations
- Safety and effectiveness in patients below 12 years of age not established
- No dose adjustment necessary for elderly patients
- No dose adjustment necessary for patients with renal impairment
- No dose adjustment necessary for patients with mild hepatic impairment. Consider maximum daily dose of 30 mg for patients with moderate hepatic impairment
Overdose Effects
No reports of significant overdose. No death or severe adverse events reported with high doses
Therapeutic Class
Proton Pump Inhibitor
Storage Conditions
Store below 30°C temperature, in a dry place, protected from light. Keep out of reach of children
Related Brands
- Dextac 30 mg (Capsule (Enteric Coated)) - navana-pharmaceuticals-ltd
- Dextac 60 mg (Capsule (Enteric Coated)) - navana-pharmaceuticals-ltd
- Delanzo 30 mg (Capsule (Enteric Coated)) - nuvista-pharma-ltd
- Delanzo 60 mg (Capsule (Enteric Coated)) - nuvista-pharma-ltd
- Regler 30 mg (Capsule (Enteric Coated)) - healthcare-pharmaceuticals-ltd